Monashee Investment Management LLC
Position in MLTX — MoonLake Immunotherapeutics
CIK 1627608
Boston, MA
Position in MLTX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,460,250
-$1,060,750 QoQ
Shares Held
75,000
+50.0% QoQ
Ownership
0.088%
of shares outstanding
% of Portfolio
2.70%
of 13F equity value
Holder Rank
#75
of 171 holders
Holding Since
Jun 2022
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MLTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Monashee Investment Management LLC holds $22,073,925 across 9 Biotechnology names. MLTX ranks #6 (6.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SLDB |
Solid Biosciences Inc.
|
500,000 | $4,995,000 | |
| 2 | SYRE |
Spyre Therapeutics, Inc.
|
50,000 | $4,439,000 | |
| 3 | TNGX |
Tango Therapeutics, Inc.
|
100,000 | $3,126,000 | |
| 4 | LEGN |
Legend Biotech Corp
|
85,385 | $2,465,918 | |
| 5 | QURE |
uniQure N.V.
|
45,000 | $2,072,700 | |
| 6 | MLTX |
MoonLake Immunotherapeutics
This page
|
75,000 | $1,460,250 | |
| 7 | TSHA |
Taysha Gene Therapies, Inc.
|
200,000 | $1,362,000 | |
| 8 | IMA |
ImageneBio, Inc.
|
192,344 | $1,134,829 |
All Filings in MLTX
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,460,250 | 75,000 | Shares | Sole | 2026-08-13 | |
| 2024-09-30 | $2,521,000 | 50,000 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $2,198,500 | 50,000 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $5,776,450 | 115,000 | Shares | Sole | 2024-05-14 | |
| 2023-09-30 | $2,850,000 | 50,000 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $2,550,000 | 50,000 | Shares | Sole | 2023-08-10 | |
| 2022-09-30 | $1,489,493 | 191,945 | Shares | Sole | 2022-11-01 | |
| 2022-06-30 | $1,050,000 | 200,000 | Shares | Sole | 2022-08-12 | |
| No filing history on record for this holder in this stock. | ||||||